Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erminia Massarelli

Showing results (11-20 of 117) with videos related to

Pageof 12
Sort By:
Cancer Treatment and Research|February 14, 2018
Perspectives in Head and Neck Medical OncologyIdoroenyi Amanam, Rohan Gupta, Alain Mita, et al.
Vaccines|February 26, 2025
Current Development of Therapeutic Vaccines in Lung CancerJesus Salvador Flores Banda, Sanjana Gangane, Fatima Raza, et al.
Cancers|July 24, 2021
Immunotherapy in Non-Small Cell Lung Cancer Patients with Brain Metastases: Clinical Challenges and Future DirectionsRanjan Pathak, Arya Amini, Addie Hill, et al.
Translational Lung Cancer Research|June 19, 2025
Neoadjuvant tepotinib in stage IIB N0 non-small cell lung carcinoma with <i>MET</i> exon 14 skipping mutation: a case report and review of the literatureAmanda Reyes, Rebecca Pharaon, Atish Mohanty, et al.
Translational Lung Cancer Research|March 26, 2015
Immunotherapy in lung cancerErminia Massarelli, Vassiliki Papadimitrakopoulou, James Welsh, et al.
Journal of Thoracic Disease|November 4, 2020
Biomarkers in immunotherapy: literature review and future directionsRebecca Pharaon, Maria A Koczywas, Sabrina Salgia, et al.
Journal for Immunotherapy of Cancer|June 6, 2018
Radiation therapy and PD-1/PD-L1 blockade: the clinical development of an evolving anticancer combinationJun Gong, Thang Q Le, Erminia Massarelli, et al.
The Oncologist|August 11, 2021
Immune Checkpoint Inhibitor-Induced Myocarditis with Myositis/Myasthenia Gravis Overlap Syndrome: A Systematic Review of CasesRanjan Pathak, Anjan Katel, Erminia Massarelli, et al.
Expert Opinion on Investigational Drugs|March 18, 2020
FAK-targeted and combination therapies for the treatment of cancer: an overview of phase I and II clinical trialsAtish Mohanty, Rebecca R Pharaon, Arin Nam, et al.
Lung Cancer (Amsterdam, Netherlands)|March 15, 2013
Uncommon epidermal growth factor receptor mutations in non-small cell lung cancer and their mechanisms of EGFR tyrosine kinase inhibitors sensitivity and resistanceErminia Massarelli, Faye M Johnson, Heidi S Erickson, et al.
Pageof 12

Showing results (11-20 of 117) with videos related to

Sort By:
Pageof 12
Cancer Treatment and Research|February 14, 2018
Perspectives in Head and Neck Medical OncologyIdoroenyi Amanam, Rohan Gupta, Alain Mita, et al.
Vaccines|February 26, 2025
Current Development of Therapeutic Vaccines in Lung CancerJesus Salvador Flores Banda, Sanjana Gangane, Fatima Raza, et al.
Cancers|July 24, 2021
Immunotherapy in Non-Small Cell Lung Cancer Patients with Brain Metastases: Clinical Challenges and Future DirectionsRanjan Pathak, Arya Amini, Addie Hill, et al.
Translational Lung Cancer Research|June 19, 2025
Neoadjuvant tepotinib in stage IIB N0 non-small cell lung carcinoma with <i>MET</i> exon 14 skipping mutation: a case report and review of the literatureAmanda Reyes, Rebecca Pharaon, Atish Mohanty, et al.
Translational Lung Cancer Research|March 26, 2015
Immunotherapy in lung cancerErminia Massarelli, Vassiliki Papadimitrakopoulou, James Welsh, et al.
Journal of Thoracic Disease|November 4, 2020
Biomarkers in immunotherapy: literature review and future directionsRebecca Pharaon, Maria A Koczywas, Sabrina Salgia, et al.
Journal for Immunotherapy of Cancer|June 6, 2018
Radiation therapy and PD-1/PD-L1 blockade: the clinical development of an evolving anticancer combinationJun Gong, Thang Q Le, Erminia Massarelli, et al.
The Oncologist|August 11, 2021
Immune Checkpoint Inhibitor-Induced Myocarditis with Myositis/Myasthenia Gravis Overlap Syndrome: A Systematic Review of CasesRanjan Pathak, Anjan Katel, Erminia Massarelli, et al.
Expert Opinion on Investigational Drugs|March 18, 2020
FAK-targeted and combination therapies for the treatment of cancer: an overview of phase I and II clinical trialsAtish Mohanty, Rebecca R Pharaon, Arin Nam, et al.
Lung Cancer (Amsterdam, Netherlands)|March 15, 2013
Uncommon epidermal growth factor receptor mutations in non-small cell lung cancer and their mechanisms of EGFR tyrosine kinase inhibitors sensitivity and resistanceErminia Massarelli, Faye M Johnson, Heidi S Erickson, et al.
Pageof 12